Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-04-15 @ 4:58 PM
Study NCT ID:
NCT01762033
Status:
TERMINATED
Last Update Posted:
2016-01-20
First Post:
2012-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma
Sponsor:
Lpath, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-17
First Submit QC Date:
None
Study First Post Date:
2013-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-18
Last Update Post Date:
2016-01-20
Last Update Post Date Type:
ESTIMATED